Assoc. Prof. Dr.  Halil Ibrahim Erdoğdu – infectious diseases – Excellence in Research

Posted on by sciencefather

Assoc. Prof. Dr.  Halil Ibrahim Erdoğdu - infectious diseases - Excellence in Research

Kafkas University - Turkey

Author Profile 

SCOPUS 

ORCID 

🎓 Early academic pursuits

Halil Ibrahim Erdoğdu began his journey in medicine at dicle university faculty of medicine, where he studied from 1985 to 1991. after graduating in 1991, he pursued specialization in internal medicine between 1994 and 1998. his early academic focus laid the foundation for his future contributions to internal medicine, nephrology, and immunology, drawing interdisciplinary parallels with advanced technological systems like power electronics, emphasizing precision and control in medical interventions.

🏥 Professional endeavors

Following his specialization, dr. erdoğdu served at kars state hospital from 1998 to 2015, significantly impacting regional healthcare. since 2015, he has been a dedicated clinician and educator at the internal medicine clinic of kafkas university. his clinical excellence is paired with responsibilities as the statistics editor for the kafkas journal of medical sciences, showcasing his dual focus on patient care and academic quality, much like the regulated flow in power electronics systems ensuring efficiency and stability.

🔬 Contributions and research focus

Dr. Erdoğdu’s research concentrates on immunology, hemodialysis, and infectious diseases. his notable studies include the evaluation of vaccine responses in hemodialysis patients and elderly populations, such as the investigation into the level of response to covid-19 vaccine in hemodialysis patients. these studies aim to enhance public health through data-driven insights, infectious diseases integrating methodologies akin to diagnostic precision in power electronics—optimizing performance through feedback mechanisms and individual-based adaptation.

🌍 Impact and influence

With publications in renowned journals such as clinical and experimental nephrology, heart lung and circulation, and current microbiology, dr. erdoğdu's work has influenced both national and international academic communities. his research on vaccine efficacy and public awareness contributes significantly to patient education and public health planning, especially in high-risk infectious diseases groups like the elderly and those undergoing dialysis.

📚 Academic citations

Dr. Erdoğdu’s scientific contributions are reflected in his academic impact, with an h-index of 6 and i-10 index of 5 according to google scholar. his scopus author profile (id: 57190609988) also infectious diseases confirms a solid record of peer-reviewed research, further affirming his role in advancing internal medicine research.

🛠️ Legacy and future contributions

With several published books (isbn: 978-625-8065-78-7, 978-625-8324-24-2, among others) and continuing engagement in research, dr. erdoğdu is committed to mentoring new professionals and enhancing the scientific community’s understanding of immunological responses and chronic disease management. his future work is expected to integrate more translational research, further linking theoretical knowledge with practical application in clinical settings.

Notable Publications 

  1. Title: Can complete blood cell count parameters predict deep vein thrombosis? / Mogu li parametri kompletne krvne slike predvidjeti duboku vensku trombozu?
    Authors: Tural, K.; Kara, F.; Avcı, S.; Erdoğdu, H.İ.
    Journal: Acta Clinica Croatica (2020)

  2. Title: Factors affecting inadequate response to HBV vaccine in hemodialysis patients: northeast Anatolia survey with six hemodialysis centers
    Authors: Erdoğdu, H.İ.; Atalay, E.; Gürsoy, G.; Canbakan, B.; Aktürk, S.; Yazıcı, C.; Yücel, O.; Mersin, S.; Üçer, S.; Merhametsiz, Ö. et al.
    Journal: Clinical and Experimental Nephrology (2019)

  3. Title: Hypoalbuminemia and related factors in hemodialyzed patients: A study of six centers in Turkey / Hemodiyaliz hastalarında hipoalbüminemi ve ilişkili faktörler: Türkiye’de altı merkezli bir çalışma
    Authors: Erdoğdu, H.İ.; Atalay, E.
    Journal: Haseki Tip Bulteni (2019)

  4. Title: The C-Reactive Protein to Albumin Ratio Predicts Acute Kidney Injury in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
    Authors: Karabağ, Y.; Çağdaş, M.; Rencuzogullari, I.; Karakoyun, S.; Artaç, İ.; İliş, D.; Yesin, M.; Çiftçi, H.; Erdoğdu, H.I.; Tanboğa, I.H.
    Journal: Heart Lung and Circulation (2019)

  5. Title: The relationship between C-reactive protein/albumin ratio and 1-year mortality in hospitalized elderly COPD patients with acute exacerbation / Akut KOAH atağı ile hastaneye yatırılan yaşlı hastalarda 1 yıl mortalite ile C-reaktif protein/albumin oranı arasındaki ilişkinin değerlendirilmesi
    Authors: Atalay, E.; Erdoğdu, H.İ.; Tur, B.K.; Deniz Balyen, L.S.; Karabağ, Y.; Ardiç, S.
    Journal: Turk Geriatri Dergisi (2019)

Dr. Angela Cano Yuste – Infectious DIseases – Best Researcher Award

Posted on by sciencefather

Dr. Angela Cano Yuste - Infectious DIseases - Best Researcher Award

Reina Sofia University Hospital/IMIBIC - Spain 

Author Profile 

SCOPUS 

Early academic pursuits 🎓

Angela Cano Yuste embarked on her academic journey at the Universidad de Córdoba, where she earned her degree in Medicine and Surgery in 2005. Driven by a passion for healthcare and community service, she further specialized in Family and Community Medicine at the Reina Sofia University Hospital, completing her training in 2010. Her quest for knowledge led her to pursue a Master’s in Research Methodology at the Universidad de Córdoba, which she completed in 2017. Angela’s academic achievements culminated in earning a Ph.D. in Medicine from the Biomedicine Program at the Universidad de Córdoba in 2023, solidifying her expertise in the field.

Professional endeavors 👨‍🌾

Angela’s professional career is marked by her dedication to both clinical practice and research. She began her career as an Emergency Physician at the Hospital de Montilla, serving from 2010 to 2018. In 2015, she joined FISEVI-FIBICO as an Investigator in the Infectious Diseases department, where she contributed significantly until 2021. Currently, Angela serves as a Specialist in Infectious Diseases at the Hospital Universitario Reina Sofia, a position she has held since 2021. Her role involves addressing complex infectious diseases, where she applies her extensive knowledge and experience to improve patient outcomes.

Contributions and research focus 🔧

Angela’s research is deeply rooted in the study and management of infectious diseases. Her work has primarily focused on complicated infections, including hospital-acquired pneumonia and Infectious DIseases infections caused by carbapenem-resistant Enterobacteriaceae. Angela has been instrumental as a Principal Investigator in several clinical trials, including those focused on complicated intra-abdominal infections in septic patients and interventional trials targeting hospital-acquired pneumonia and complicated infections. Her research efforts aim to advance the understanding and treatment of these critical conditions, contributing to better clinical practices and patient care.

Accolades and recognition 🌟

Throughout her career, Angela has garnered respect and recognition for her contributions to the field of infectious diseases. Her leadership in clinical trials and her commitment to advancing Infectious DIseases medical research have earned her accolades within the scientific and medical communities. Angela’s work in high-impact clinical studies reflects her dedication to improving healthcare outcomes through rigorous research and evidence-based practice.

Impact and influence 🌍

Angela’s impact extends beyond her immediate clinical and research responsibilities. Her work in infectious diseases has influenced treatment protocols and contributed to the global Infectious DIseases understanding of managing complex infections. Her research findings have helped shape strategies for combating antibiotic-resistant bacteria and improving patient care in hospital settings. Angela’s influence is evident in her contributions to medical literature and her role in guiding future research directions in infectious diseases.

Legacy and future contributions 🔄

Angela Cano Yuste’s legacy lies in her unwavering commitment to medical excellence and research innovation. As she continues her work at the Hospital Universitario Reina Sofia, Angela remains at the forefront of infectious disease research and clinical practice. Her future contributions are poised to further advance the field, particularly in developing new treatment protocols and managing emerging infectious threats. Angela’s dedication ensures that her impact will resonate within the medical community for years to come, inspiring future generations of healthcare professionals..

Notable publications 

  • Title: Invasive aspergillosis in liver transplant recipients in the current era
    Authors: Kimura, M., Rinaldi, M., Kothari, S., Selzner, N., Husain, S.
    Journal: American Journal of Transplantation, 2024, 24(11), pp. 2092–2107
  • Title: Long-Term Clinical and Ecological Impact of an Antimicrobial Stewardship Program on the Incidence of Carbapenem-Resistant Klebsiella pneumoniae Infections in a High-Endemic Hospital
    Authors: López-Viñau, T., Muñoz-Rosa, M., Ruiz-Lara, L.M., Martínez-Martínez, L., Torre-Cisneros, J.
    Journal: Antibiotics, 2024, 13(9), 792
  • Title: Risk factors for bloodstream infections due to carbapenem-resistant Enterobacterales: a nested case-control-control study
    Authors: Zhou, H., Buetti, N., Pérez-Galera, S., Ozakin, C., Layunta-Acero, R.
    Journal: Journal of Antimicrobial Chemotherapy, 2024, 79(9), pp. 2132–2141
  • Title: Efficacy and safety of a structured de-escalation from antipseudomonal β-lactams in bloodstream infections due to Enterobacterales (SIMPLIFY): an open-label, multicentre, randomised trial
    Authors: López-Cortés, L.E., Delgado-Valverde, M., Moreno-Mellado, E., Díaz-López, M.D., Paño, J.R.
    Journal: The Lancet Infectious Diseases, 2024, 24(4), pp. 375–385
  • Title: Attributable mortality of infections caused by carbapenem-resistant Enterobacterales: results from a prospective, multinational case-control-control matched cohorts study (EURECA)
    Authors: Paniagua-García, M., Bravo-Ferrer, J.M., Pérez-Galera, S., Sahin, A., Akalin, H.
    Journal: Clinical Microbiology and Infection, 2024, 30(2), pp. 223–230